FREE DAILY STOCK MARKET NEWS

FREE DAILY STOCK MARKET NEWS

COMPANY LOGO

COMPANY OVERVIEW

Little Green Pharma, together with its exclusive manufacturing and distribution partners, holds all the necessary licenses and permits to operate and is a vertically integrated medicinal cannabis company. The company is a differentiated player in the rapidly expanding medical cannabis market and is driven by a strong belief that everybody deserves good health.

Little Green Pharma

Little Green Pharma Grow German Roots

Little Green Pharma Grow German Roots

Continuing to build its European footprint, Little Green Pharma has shipped its new high THC strain medicinal cannabis flower product to Illios Sante in Germany as the first delivery of a massive two-year supply deal with a minimum value of approximately $AUD2.3...

Little Green Pharma balance books for growth

Little Green Pharma balance books for growth

Little Green Pharma is set to strengthen its balance sheet and break even having secured firm commitments for a $AUD5 million dollar placement supporting the Company's pathway to break even and achieve significant growth at scale. This comes right on the heels of the...

Little Green Pharma Makes Psychedelic Partnership

Little Green Pharma Makes Psychedelic Partnership

Things continue to heat up for Little Green Pharma, with its psychedelic subsidiary Reset Mind Sciences entering a strategic alliance with the Health Insurance Fund of Australia to develop a proof-of-concept mental health treatment facility with the capability to...

Little Green Pharma approved for psilocybin trial

Little Green Pharma approved for psilocybin trial

Little Green Pharma is moving into the next stage of its alternative medicine business with its subsidiary Reset Mind Sciences receiving ethics approval to conduct a clinical trial concerning the use of psilocybin to treat patients with treatment-resistant major...

New avenue for alternative medicine

New avenue for alternative medicine

A new avenue has opened up in Australia for alternative medicine producers, with the Therapeutic Goods Administration permiting the prescription of MDMA for the treatment of post-traumatic stress disorder and psilocybin, more commonly known as magic mushrooms, for...

Little Green Pharma deepen German roots

Little Green Pharma deepen German roots

Little Green Pharma continues growing into the German medicinal cannabis market, signing its second supply deal with alternative medicine giant Cannamedical, set to bring in a minimum $4.5 million dollars over the next two years. The news comes just days after the...

LGP secure sleep study approval

LGP secure sleep study approval

Little Green Pharma can now progress to Phase III of the SleepWell study after securing ethics approval to support proposed Australian Schedule 3 registration for CBD products to reduce stress and improve quality of sleep. It is another significant step towards an...

Little Green Pharma growing at home

Little Green Pharma growing at home

Little Green Pharma have delivered over 6500 units of three new branded and high-THC medicinal cannabis products from its Danish facility into the Australian market. It represents both the commercialisation of its Danish facility and a growing LGP presence into an...

LGP accelerating sales

LGP accelerating sales

Having just locked in a massive new German supply deal worth potentially $4.5 million dollars, Little Green Pharma is extending its roots and have received firm commitments for a $4 million dollar placement alongside a $2 million dollar share purchase plan for...